Home
Resources
Publications
Meclosorb, a New Topical Antibiotic Agent in the Treatment of Acne Vulgaris: A Double-Blind Clinical Study

Meclosorb, a New Topical Antibiotic Agent in the Treatment of Acne Vulgaris: A Double-Blind Clinical Study

N Hjorth, H Schmidt, K Thomsen, K Dela

Acta Derm Venereol. 1984;64(4):354-7.

PMID: 6209900

Abstract:

The clinical effect on acne vulgaris of topical treatment with meclocycline sulfosalicylate and systemic treatment with peroral tetracycline (500 mg daily) was compared in a double-blind study of 60 patients treated for 8 weeks. The reducing effect of Meclosorb cream and tetracycline tablets on the number of closed comedones, pustules, papules and cysts was marked and not significantly different. The effect of Meclosorb on open comedones was weak and of slow onset. No side effects were registered. Topical treatment with Meclosorb is an effective and safe alternative to systemic tetracycline treatment of acne vulgaris.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP73816429	Meclocycline sulfosalicylate		73816-42-9	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: